title: Management and monitoring of cancer-associated retinopathy.
abstract: Cancer-associated retinopathy is a rare paraneoplastic event that can involve allergic reactions and result in retinal degradation. A patient, who had a 35-year smoking history, complained of visual loss and was found to have serum antibodies that reacted with an extract of retina, including the previously described retinal cancer-associated retinopathy antigen. Prednisone treatment appeared to reduce the patient's antibody titers to normal levels. Visual fields stabilized, and the patient was able to maintain useful vision throughout the course of treatment until his death 1 year following initial diagnosis. To our knowledge, this is the first reported case in which monitoring of antibody responses to retinal antigens appeared to be useful in the decision whether to initiate prednisone therapy. Rising antibody titers to the cancer-associated retinopathy antigen probably occurs before progressive visual field loss and may be considered an indication for prompt steroid therapy.
authors.affiliation: Department of Ophthalmology, University of California, Davis, Medical Center 95816.
authors.forename: J L
authors.initials: JL
authors.lastname: Keltner
authors.forename: C E
authors.initials: CE
authors.lastname: Thirkill
authors.forename: N K
authors.initials: NK
authors.lastname: Tyler
authors.forename: A M
authors.initials: AM
authors.lastname: Roth
mesh_terms: D000368:Aged; D000951:Antigens, Neoplasm / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood; D015153:Blotting, Western; D001932:Brain Neoplasms / Q000556:secondary; D002135:Calcium-Binding Proteins; D018288:Carcinoma, Small Cell / Q000276:immunology* / Q000473:pathology; D004797:Enzyme-Linked Immunosorbent Assay; D005136:Eye Proteins; D005500:Follow-Up Studies; D051597:Hippocalcin; D006801:Humans; D008074:Lipoproteins; D008175:Lung Neoplasms / Q000276:immunology* / Q000473:pathology; D008297:Male; D008991:Monitoring, Physiologic; D009419:Nerve Tissue Proteins; D010257:Paraneoplastic Syndromes; D011241:Prednisone / Q000627:therapeutic use; D051603:Recoverin; D012164:Retinal Diseases / Q000188:drug therapy* / Q000276:immunology; D014794:Visual Fields
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002135:Calcium-Binding Proteins; D005136:Eye Proteins; D008074:Lipoproteins; D009419:Nerve Tissue Proteins; C496731:RCVRN protein, human; D051603:Recoverin; D051597:Hippocalcin; D011241:Prednisone